<DOC>
	<DOCNO>NCT00695539</DOCNO>
	<brief_summary>This single-arm , phase IV , open-label , prospective , non interventional study evaluate efficacy , tolerability safety rosuvastatin administer 24 week approximately 900 Greek subject hypercholesterolemia normal clinical practice .</brief_summary>
	<brief_title>Rosuvastatin Efficacy Safety Evaluation Hypercholesterolaemic Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Patients hypercholesterolaemia already treatment rosuvastatin accord approve SPC longer 1 month prior study entry Patients able read , understand sign Patient Information &amp; Consent Form Patients willing comply study requirement Patients likely comply study requirement Patients currently participate participate 3 month period prior study entry another clinical trial Female child bear potential use reliable method contraception . Pregnancy lactation . Patients meet contraindication describe approve SPC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Rosuvastatin</keyword>
	<keyword>hypercholesterolaemia</keyword>
</DOC>